Mass spectrometry-based quantitation of cervicovaginal progesterone and steroids in women at high risk of preterm birth
Clicks: 4
ID: 324653
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.9
/100
4 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #22 of 28 articles by views in molecular human reproduction
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Placental production of steroids, like progesterone, drives increasing circulating concentrations during pregnancy. It is postulated that reduced cervicovaginal progesterone contributes to cervical shortening and increased preterm birth (PTB) risk. Although vaginal progesterone is recommended for PTB prevention, its effectiveness remains uncertain. While serum and urinary progesterone are routinely measured in pregnancy, little is known about cervicovaginal fluid (CVF) progesterone concentrations. To address this, we adapted existing mass spectrometry-based assays to quantify 13 steroid hormones in CVF collected between 12-24 weeks gestation from uncomplicated term pregnancies (n = 14) and those with adverse outcomes (n = 11). Only progesterone, androstenedione, and cortisol were detected above detection limits. In uncomplicated term pregnancies, mean concentrations of these steroids were 6.61 ± 8.13, 4.16 ± 2.98 and 0.34 ± 0.21 ng/g of CVF, respectively. Cervicovaginal progesterone was weakly, positively associated with gestational age (r2= 0.15, p-value= 0.02) which was also observed in paired samples collected at 12 and 22 weeks (n = 5, paired Wilcoxon, p-value = 0.03). No differences in CVF steroid levels were observed between women who subsequently delivered preterm (n = 9) or at term (n = 15). Our study provides a robust method for quantifying CVF steroids and suggests that second-trimester PTB risk is not associated with cervicovaginal progesterone concentrations.
| Reference Key |
openalex_W7202177070
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Katia Capuccini, Gonçalo D S Correia, Lucía Olmo García, Charis Uhlson, Ada H Y Yuen, Belen Gimeno-Molina, Lynne Sykes, Zoltán Takáts, Robert Murphy, Phillip R Bennett, David A. MacIntyre |
| Journal | molecular human reproduction |
| Year | 2026 |
| DOI |
10.1093/molehr/gaag045
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.